Optimizing Nutritional Support in Advanced Non-Small Cell Lung Cancer: Evidence and Controversies in Oral, Enteral, and Parenteral Approaches.
Malnutrition and cachexia affect the majority of patients with advanced lung cancer, driven by systemic inflammation (IL-6, TNF-α), metabolic dysregulation, and anorexia. These conditions worsen prognosis, reduce treatment tolerance, and diminish quality of life (QoL) and survival. Early recognition...
| Publicado en: | Nutrition & Cancer Vol. 78; no. 4/5; pp. 265 - 279 |
|---|---|
| Autores principales: | , , , , , , , , , |
| Formato: | algorithm review tables/charts Journal Article |
| Publicado: |
Taylor & Francis Ltd
2026
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=192954171&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 192954171 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 01635581 7MS jtl: Nutrition & Cancer issn: 01635581 maglogo: N pubinfo: dt: 2026 vid: 78 iid: 4/5 pid: 377 pub: Taylor & Francis Ltd place: Philadelphia, Pennsylvania artinfo: ui: 192954171 191830786 192954171 192954171 10.1080/01635581.2026.2632656 192954171 ppf: 265 ppct: 14 formats: fmt: – @attributes: type: T – @attributes: type: P tig: atl: Optimizing Nutritional Support in Advanced Non-Small Cell Lung Cancer: Evidence and Controversies in Oral, Enteral, and Parenteral Approaches. aug: au: Obomanu, Elvis Ugwu, Chidiebube Megiso, Muluken Jones, Colton Verinumbe, Tarfa Ratnani, Akshay King, Sam Palaferro, Danielle Hlaing, Swe Swe Cohn, Zachary affil: Department of Internal Medicine, Jefferson-Einstein Hospital, Philadelphia, PA, USA sug: subj: Nutritional Support Carcinoma, Non-Small-Cell Lung Drug Therapy Enteral Nutrition Administration, Oral Parenteral Nutrition Dietary Supplements Therapeutic Use Cachexia Drug Therapy Quality of Life Appetite Stimulating Agents Therapeutic Use Inflammation Complications Patient Centered Care Palliative Care Deglutition Disorders Complications Gastrointestinal Motility Consent Cultural Diversity Healthcare Disparities Anorexia Complications Malnutrition Complications Nutritional Status Dietary Proteins Administration and Dosage Weight Gain Biological Markers Blood Infection Risk Factors Carcinoma, Non-Small-Cell Lung Prognosis Exercise Ethics, Medical Patient Autonomy Cultural Values Health Services Accessibility Appetite Physiology Biochemical Phenomena Adipose Tissue Distribution Muscle, Skeletal Physiology Immunity Functional Status Phenotype Dose-Response Relationship Chemoradiotherapy Adverse Effects Energy Metabolism Hydration Status Decision Making Advance Directives Muscle Strength Cytokines Blood ab: Malnutrition and cachexia affect the majority of patients with advanced lung cancer, driven by systemic inflammation (IL-6, TNF-α), metabolic dysregulation, and anorexia. These conditions worsen prognosis, reduce treatment tolerance, and diminish quality of life (QoL) and survival. Early recognition, utilizing tools such as the Patient-Generated Subjective Global Assessment (PG-SGA), is crucial. Nutritional support should align with patient-centered goals, prioritizing function and QoL rather than survival alone. Oral nutritional supplements (ONS), especially high-protein/EPA (eicosapentaenoic acid)- enriched formulas, enhance weight, muscle mass, and QoL but often face adherence challenges. Enteral nutrition (EN) supports patients with functional GI tracts and impaired intake (e.g., dysphagia), improving biomarkers and reducing complications. Parenteral nutrition (PN) should be limited to patients with intestinal failure due to infection risks and minimal survival benefits. Multimodal care, encompassing nutrition, exercise, and pharmacotherapy (e.g., appetite stimulants, investigational agents such as anamorelin), is crucial. Ethical, cultural, and legal considerations must guide decisions around artificial nutrition, emphasizing autonomy, informed consent, and respect for cultural beliefs. Barriers such as inconsistent screening and limited resources persist. Future research should focus on lung cancer-specific trials of EN, standardized cachexia definitions, and equitable access to nutritional support, especially in underserved populations. pubtype: Academic Journal doctype: algorithm review tables/charts Journal Article ougenre: Article language: English refInfo: holdings: @attributes: islocal: N |
|---|